Profiling of Immune-related Network Assessment in Cholangiitis Encompassing Adverse Effects

Profiling of Immune-related Network Assessment in Cholangiitis Encompassing Adverse Effects - PINACEAE Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056863

Enrollment

Registered

2025-01-30

Start date

2025-01-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune-related Adverse Event (irAE) Cholangiitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients scheduled for endoscopic retrograde cholangiopancreatography (ERCP) and blood tests

Exclusion criteria

Exclusion criteria: Women who are pregnant or may be pregnant

Design outcomes

Primary

Measure	Time frame
Analyze the lymphocyte subset composition of the cholangial mucosa and bile, particularly regulatory T cells, using flow cytometry, and calculate the diagnostic ability for the group with irAE cholangiitis.	—

Countries

Japan

Contacts

Public ContactMasaya Iwamuro

Okayama University Hospital Department of Gastroenterology

iwamuromasaya@yahoo.co.jp0862357219

Outcome results